Evidence map›Paper›PMID 36448873›Full record

ReviewClinical pharmacology and therapeutics2023

Beyond the Individual: Community-Centric Approaches to Increase Diversity in Biomedical Research.

Karen E Brown, Alison E Fohner, Erica L Woodahl

Abstract readReview
In one paragraph

Review in Clinical pharmacology and therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Participant diversity in ACER: 2010-2022.Alcohol, clinical & experimental research · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karen E BrownL.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, Montana, USA.ORCID 0000-0002-9866-3237
Alison E FohnerDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4231-3331
Erica L WoodahlL.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, Montana, USA.ORCID 0000-0002-0413-4140

Funding

Vitamin K gene network: Variant discovery and characterizationP01GM116691 · NIGMS · UNIVERSITY OF WASHINGTON · PI THUMMEL, KENNETH E. · 2016 to 2020
$7.6M
Community-engaged Research Toward Precision Medicine with AIAN PeopleR01HG009500 · NHGRI · UNIVERSITY OF ALASKA FAIRBANKS · PI BOYER, BERT BRANDON, DILLARD, DENISE A · 2017 to 2019
$2.0M
Integrated multi-omics approach to identify early protein biomarkers in Alzheimer's disease and cognitive declineK01AG071689 · NIA · UNIVERSITY OF WASHINGTON · PI FOHNER, ALISON ELIZABETH · 2022 to 2025
$488k
NHGRI NIH HHS R01 HG009500NIA NIH HHS K01 AG071689NIGMS NIH HHS P01 GM116691
6 · The paper itself

Abstract

Community-centric approaches to engage underrepresented populations-including community engagement, community-level consent practices, and capacity development for research-are means to enhance diversity in biomedical research populations in a more ethical way. Low diversity is a known problem in biomedical research that presents challenges in translating the benefits of research to the global population. Through long-term partnerships built on trust and collaboration, communities who would otherwise avoid research may be more willing to participate. When communities are engaged in research as partners and research questions are motivated by community health priorities, research is more meaningful and research methods are more respectful. Conversely, a lack of consultation throughout the research process can further alienate the very communities that these efforts are designed to engage. A number of underserved populations-for example American Indian and Alaska Native peoples-may value the benefits of research to a community equally or more than individual benefits. A community's autonomy must be considered, particularly when that community is not adequately protected by traditional informed consent processes. Opportunities for capacity development to support collaborative partnerships between communities and researchers are required to support engagement and understanding of the research process. Changes to research processes and infrastructure that encourage a higher level of research oversight within the community should be supported. In this paper, we present approaches that may improve diversity and equitable access to research and the delivery of health innovations for people that have historically been left out of biomedical research.

Indexed as

Biomedical ResearchHealth PrioritiesHumansResearch DesignResearch PersonnelVulnerable Populations

Identifiers

PMID36448873
PMCPMC12162141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.